The Peri‐procedural Use of Dabigatran in Patients Undergoing Left Atrial Ablation for Atrial Fibrillation
Riyaz Somani(University of Leicester), Kevin Michael(Queen's University), Damian Redfearn(Queen's University), Kiarash Mohajer(Queen's University), Charlotte Haley(Queen's University), Christopher S. Simpson(Queen's University), Adrián Baranchuk(Population Health Research Institute), Hoshiar Abdollah(Queen's University)
Cited by 10
Related Papers
Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: A systematic review and meta-analysis
|International Journal of Cardiology|2017|103
Frailty and Mortality Outcomes After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
|Journal of the American Medical Directors Association|2017|89
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties
|Diabetes and Vascular Disease Research|2012|80
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
|Journal of Thrombosis and Haemostasis|2007|69